ioGenetics is seeking partnering in two broad areas: • New biotherapeutic and diagnostic development, including design and development of antibody-based products, epitope peptides, and vaccines, based on epitope mapping. Applications include products for diagnosis or management of infectious diseases, allergy, autoimmunity, and cancer. • Partners with needs for in depth immunomic mapping of mammalian, microbial or plant proteins, including evaluation of biotherapeutic antigenicity, patient stratification, and identification of mimics and cryptic epitopes.